Simplex Trading
FHTX icon

Simplex Trading’s Foghorn Therapeutics FHTX Stock Holding History

Simplex Trading’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$315 Buy
+66
New +$362 ﹤0.01% 8791
2025
Q3 		– Sell
-160
Closed -$848 – 9346
2025
Q2 		$0 Sell
160
-1,622
-91% -$6.78K ﹤0.01% 8963
2025
Q1 		$6K Buy
1,782
+1,102
+162% +$5.02K ﹤0.01% 7433
2024
Q4 		$3K Buy
+680
New +$4.95K ﹤0.01% 7869
2024
Q2 		– Sell
-2,119
Closed -$14K – 9074
2024
Q1 		$14K Buy
+2,119
New +$11.8K ﹤0.01% 7370
2023
Q1 		– Sell
-66
Closed – – 9334
2022
Q4 		$0 Buy
+66
New +$498 ﹤0.01% 9531
2022
Q2 		– Sell
-42
Closed -$542 – 10285
2022
Q1 		$0 Sell
42
-5,506
-99% -$75.6K ﹤0.01% 10690
2021
Q4 		$126K Buy
+5,548
New +$79.7K ﹤0.01% 5883

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Simplex Trading's FHTX Position: Q1 2026 in Review

Simplex Trading opened a new position in Foghorn Therapeutics (FHTX) in Q1 2026: 66 shares worth $315. The stake represents ﹤0.01% of the portfolio and ranks #8791 among its holdings. This is a return to the name: Simplex Trading previously reported a position in FHTX as recently as Q2 2025.

Simplex Trading first reported a position in FHTX in Q4 2021 and has held it in 8 quarters since. The position peaked at $126K in Q4 2021. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Simplex Trading held 66 shares of Foghorn Therapeutics worth $315 as of Q1 2026.
  • Foghorn Therapeutics was a new Simplex Trading position in Q1 2026.
  • Foghorn Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8791 holding.
  • Simplex Trading first reported a position in Foghorn Therapeutics in Q4 2021 and has held it in 8 quarters since.
  • Simplex Trading's Foghorn Therapeutics position peaked at $126K in Q4 2021.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.